What We're Reading: HIV Drug Tested in Treating Coronavirus; Preterm Birth Drug Debate; Trump Threatens Funds to California
Chinese health authorities are testing an HIV drug, lopinavir and ritonavir, as a potential treatment for the new coronavirus; a debate is growing over the efficacy of the sole drug approved to prevent preterm birth; the Trump administration threatens to withhold Califonia’s federal funding due to its abortion coverage requirements.
Chinese Authorities Test HIV Drug for Treatment of Coronavirus
Doctors Fear Repeal of Preterm Birth Drug Approval
China is undertaking tests on an HIV drug, a combination therapy of lopinavir and ritonavir (Aluvia), to examine its efficacy as a treatment for symptoms of the new coronavirus, according to drugmaker AbbVie.
California’s Federal Funding Threatened Over Abortion Health Coverage
Last Friday, the Trump administration threatened to cut federal funding from California over its requirement that private insurers cover abortions, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025